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This journal is ª The Royal Society ofOne pathway, many compounds: heterologous
expression of a fungal biosynthetic pathway reveals its
intrinsic potential for diversity†
Zahida Wasil,‡a Khomaizon A. K. Pahirulzaman,‡b Craig Butts,a Thomas J. Simpson,a
Colin M. Lazarus*b and Russell J. Cox*ac
Heterologous expression of genes from the proposed aspyridone biosynthetic cluster from Aspergillus
nidulans in the host Aspergillus oryzae led to the production of eight diﬀerent compounds in addition
to aspyridone A 1, one of the previously observed products. The pathway genes were incapable of
producing aspyridone B 2, the previously accepted ﬁnal product of the pathway. Expression of restricted
sets of genes in addition to the core polyketide synthase – nonribosomal peptide synthetase (PKS-NRPS)
genes apdA and apdC revealed: that apdE encodes a cytochrome P450 enzyme with ring-expanding
and unprecedented dephenylation activity; that apdB encodes an N-hydroxylase, an activity not
previously suspected; that the productivity of ApdA and ApdC proteins appears to be signiﬁcantly
enhanced in the presence of the downstream ApdE oxidase; and no obvious chemical roles for ApdD
and ApdG. Furthermore, the ApdC enoyl reductase appears to operate with diﬀerent stereoselectivity in
diﬀerent PKS cycles. All of these features illustrate the inherent diversity of compounds potentially
produced by the apd pathway and the high utility of a whole pathway expression strategy for
investigating and revealing new biosynthetic chemistry in fungi.Introduction
The advent of rapid and economical genome sequencing of
bacteria and fungi has revealed thousands of biosynthetic gene
clusters encoding the synthesis of secondary metabolites. In the
majority of cases the gene clusters can be rapidly annotated (e.g.
using bioinformatic tools such as AntiSmash1) and the class of
compound they specify can be identied, but it is not yet
possible to predict the precise structure of the encoded
metabolite for any given natural product biosynthetic gene
cluster. Fungi, in particular, present a problem because they can
oen contain more than 50 biosynthetic gene clusters and
because the core synthases2 and synthetases3 are oen iterative,
displaying complex and cryptic programming. Gene clusters
which have not been linked to the biosynthesis of a particular
compound are referred to as orphan clusters. The vast majority, Cantock's Close, Bristol BS8 1TS, UK.
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Chemistry 2013of fungal biosynthetic gene clusters currently fall into this
category.
Attempts have been made to link fungal biosynthetic gene
clusters with particular compounds. For example knockout or
silencing strategies can quickly achieve this if the compound of
interest is observable.4–6 However most fungal biosynthetic gene
clusters appear to be silent – that is, not transcribed at a suﬃ-
cient level to produce an observable chemical product. In the
case of such silent clusters, knockout and silencing strategies
cannot be used. A further signicant problem lies in the
complex way in which fungal gene clusters are regulated.7 Fungi
are eukaryotes and thus each structural gene (for example
encoding an individual biosynthetic enzyme) is controlled by its
own promoter. These promoters are activated under unique
(oen unknown) circumstances.
Some silent fungal biosynthetic gene clusters encode a
transcriptional regulator. In a limited number of cases, for
example that of the aspyridone A 1 biosynthetic gene cluster in
Aspergillus nidulans, it has proven possible to ‘switch on’
biosynthesis by overexpressing this transcription factor.8 This
has the eﬀect of activating the promoters of the biosynthetic
genes and thus causing transcription of the structural genes, in
turn resulting in the production of the biosynthetic proteins
themselves and the synthesis of a new compound. However,
because not all silent biosynthetic gene clusters contain a
transcription factor this method is limited.Chem. Sci., 2013, 4, 3845–3856 | 3845
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View Article OnlineFurthermore, switching on a range of genes simultaneously
does not allow the eﬀect (or the chemical programme) of each
individual biosynthetic protein to be observed, and it is also
possible that the induction of transcription factors may activate
unknown genes outside the biosynthetic gene cluster,
producing unpredictable chemical eﬀects. Numerous other
methods of activating silent fungal gene clusters have been
reported, including chemical epigenetic modication,9 manip-
ulation of signalling cascades10 and alteration of growth
conditions (e.g. the OSMAC11 approach),12 but none are
systematic, general, widely applicable in a range of fungi or,
most crucially, predictably applicable to a gene cluster of
interest.
We have been seeking to develop a systematic and general
method for investigating the biosynthetic chemistry of fungal
gene clusters based on heterologous expression – i.e. rapidly
moving genes into a tractable host organism in a cumulative
manner and observing chemical changes. We recently reported
the development of a generally applicable plasmid system in
which structural biosynthetic genes can be cloned downstream
of strong promoters, thus overcoming the cryptic native tran-
scription systems.13 The cloning vectors (Fig. 1A) feature a
fungal selection marker (e.g. argB14 for use in the arginine
auxotroph of Aspergillus oryzae M-2-3) as well as a Gateway
cassette downstream of the strong inducible amyB promoter
(PamyB) into which large fungal synth(et)ase genes can be rapidly
cloned using in vitro recombination. The vector also contains
colE1 and ampR for replication and selection in E. coli and a 2m
origin of replication and URA3 for selection in yeast. Three
further strong fungal promoters (Padh, PgpdA and Peno) are also
included so that up to three tailoring genes can be expressed in
parallel from the same system (Fig. 1B). Here we demonstrate
how this system can be used to obtain detailed chemical
information from a silent fungal gene cluster and provide
insights into new and unprecedented reactivity.Fig. 1 Schematic representation of the fungal expression vector system used in
this study. See text for abbreviations. (A) Native vector; (B), with genes for
expression; red, fungal promoter and terminator sequences; blue, fungal selec-
tion marker; grey, genes for use in yeast and E. coli; orange, in vitro recombination
cassette; green, biosynthetic genes.
3846 | Chem. Sci., 2013, 4, 3845–3856Results
Hertweck and coworkers reported the discovery of a potential
biosynthetic gene cluster in the lamentous fungus A. nidulans
centred on a large open reading frame (apdA) encoding an
iterative highly-reducing polyketide synthase (hrPKS) fused to a
single module nonribosomal peptide synthetase (NRPS).8 Such
hrPKS-NRPS genes, rst described for fusarin C15 are now
known to be a common feature in the genomes of many fungi.16
Also clustered with apdA were seven other ORFs encoding
cytochrome P450 enzymes (apdB and apdE), an enoyl reductase
(apdC), a FAD-dependent monooxygenase (apdD), an exporter
(apdF), a dehydrogenase (apdG) and a transcription factor
(apdR). Ectopic expression of apdR downstream of the inducible
alcohol dehydrogenase promoter (PalcA) in the A. nidulans strain
SB4.1 led to the production of 1 and 2 and the up-regulation of
genes apdA, apdB, apdC, apdD, apdE and apdG implicating these
in biosynthesis. While these results showed that the apd cluster
was most likely involved in aspyridone biosynthesis the precise
chemical steps and intermediates could not be established.
More recently Tang and coworkers proved that apdA and apdC
encode proteins which work together to form the precursor
preaspyridone A by in vitro reconstitution of the proteins,17 but
these experiments did not reveal information about the later
steps of biosynthesis. We reasoned that the apd cluster would
make a useful testbed for our heterologous expression tech-
nology, and the results could also allow us to delineate the
precise chemical intermediates and steps of biosynthesis
(Fig. 2).
The apdA gene encodes a hrPKS-NRPS. In the case of many
fungal hrPKS-NRPS it is known that the enoyl reductase (ER)
domain is catalytically inactive (for example the cases of tenellin
3 and desmethylbassianin 4).18 Vederas and coworkers have also
demonstrated similar behaviour in the hrPKS system respon-
sible for lovastatin biosynthesis.19 In all these cases the missing
ER functionality is supplied by a trans-acting protein usually
encoded within the same gene cluster as the PKS itself. The
apdA-encoded hrPKS-NRPS falls into this category and the apdC
gene is known to encode the trans-acting ER.17 Because hrPKS
lacking functional ER domains are known to function poorly
and erratically on their own20 we expressed apdA and apdC
together in the fungal host Aspergillus oryzae. Transformants
and untransformed controls were grown in nutrient broth
medium, acidied, extracted with EtOAc, and concentrated
residues were examined by LCMS. Three new peaks were
observed in transformants as compared to controls. These
compounds were puried by automated mass-directed reverse-
phase chromatography (Table 1).
The major component (61 mg L1) was shown to possess
molecular formula C19H25NO4 by HRMS (observed 332.1852;
calculated 332.1856 for M[H]+). 1H NMR indicated the presence
of an aliphatic group consistent with the 2,4-dimethylhexanoyl
sidechain of aspyridone and HSQC and HMBC spectra
conrmed the product to be the expected 5 based on the in vitro
work of Tang and coworkers.17 Theminor second component (6,
0.6 mg L1) possessed an identical molecular formula and a
near identical set of NMR data to 5. 1H NMR in CDCl3 revealedThis journal is ª The Royal Society of Chemistry 2013
Fig. 2 Aspyridone A 1 and B 2, related 2-pyridones tenellin 3 and desmethylbassianin 4 and the proposed apd biosynthetic gene cluster.
Table 1 Titres of compounds isolated from expression experiments; all values mg L1; tr. trace
Transformant
(total crude) 1 5 6 7 8 9 10 11 12 Total yield
Approx.
fold increase
apdAC (430) — 60.7 0.6 tr. — — — — — 61.3 —
apdACE (1126) 119.8 — — 15.0 183.6 72.2 — — — 390.6 6.5
apdABC (805) — 141.0 2.2 tr. — — — — — 143.2 2
apdAC + tenA (653) — 121.0 2.2 tr. — — — — — 123.2 2
apdACEB (300) 1.8 34.6 5.7 tr. 2.6 — 6.2 2.7 4.0 57.6 1
apdACED (448) 5.1 — 0.3 8.2 49.9 — — 8.0 71.5 1
apdACEBG (622) 12.6 98.0 — tr. 42.6 — 15.8 8.2 — 177.2 3
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View Article Onlinefractional diﬀerences (<0.05 ppm) in chemical shis for the
side-chain protons, but 1H NMR in DMSO-d6 revealed a signif-
icant diﬀerence in the coupling between methine H-5 and
methylene H-14 protons consistent with 5 and 6 being epimeric
at C-5. Minor component 6 forms crystals on standing, while 5
does not, and X-ray analysis of 6 showed it to be the 7,9-anti
isomer. Previous papers have shown a syn-dimethyl side chain
for aspyridone. Finally, a minor component with formula
C19H25NO3 (observed m/z 338.1735, calculated 338.1727 for [M]-
Na+) was observed in low yield. The same compound was
produced in higher titre in a subsequent experiment and
NMR analysis of this showed it to be the non-hydroxylated
analogue 7.
In a second experiment apdA, apdC and apdE were coex-
pressed. The apdE gene encodes a cytochrome P450 enzyme, but
its function is unknown. Transformants expressing these three
genes produced three new compounds. The major component
(184 mg L1) possessed a molecular formula of C19H25NO5 – a
single oxygen more than 5 (observed HRMS 370.1625, calcu-
lated 370.1625 for [M]Na+). 1D and 2D NMR analysis showed
this compound to be 14-hydroxypreaspyridone A 8. The second
major compound (120 mg L1) had a molecular formula of
C19H23NO4 (observed HRMS 330.1692, calculated 330.1700 for
[M]H+) and a distinctive 2-pyridone proton in the 1H NMR.
Inspection of the 1D and 2D NMR, and comparison with theThis journal is ª The Royal Society of Chemistry 2013literature values, showed this to be aspyridone A 1 itself. Crys-
tals of 1 were prepared and the X-ray structure showed that the
side-chain pendant methyls matched those of 6 in being
arranged anti. The third compound (72 mg L1) recovered from
this experiment had a molecular formula of C13H19NO3
(observed HRMS 238.1429, calculated 238.1438 for [M]H+),
corresponding to the loss of phenoxide from 1. This was
conrmed by 1D and 2D NMR and the structure was shown to
be the dephenylated 2-pyridone 9. Crystals of 9 could be
prepared, and the X-ray crystal structure conrmed the struc-
ture determined by NMR and again showed an anti arrange-
ment of the side-chain pendant methyl groups (Fig. 3).
Experiments to determine the origin of the amino acid
component of aspyridone A 1were conducted by supplementing
growing cultures of A. oryzae + apdACE with [1-13C]-tyrosine
during the fermentation. Isolated aspyridone A 1 was speci-
cally 13C-labelled at C-4 (5% incorporation), while isolated 9 was
also labelled at C-4 (13% incorporation).
Next, apdA, apdC and apdB were coexpressed. Once again
apdB encodes a cytochrome P450 monooxygenase with no
known function. In this experiment the same three compounds
were produced as by expression of apdA and apdC alone,
although the overall titre was around 2.5-fold higher. The gene
tenA also encodes a cytochrome P450 enzyme known to be
involved in the oxidative ring expansion of acyl tetramic acids toChem. Sci., 2013, 4, 3845–3856 | 3847
Fig. 3 Compounds produced from heterologous expression experiments.
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View Article Online2-pyridones. However, expression of tenA with apdA and apdC
led to the production of the same compounds as the expression
of apdA and apdC alone, although again, the overall titre was
around 2-fold higher than expression of the two genes alone.
Next, a series of 4-way coexpression experiments were per-
formed. We reasoned that apdB might function aer apdE and
so in the rst of these experiments apdA, apdC and apdE were
coexpressed with apdB. This resulted in many of the previously-
observed compounds being produced, together with three new
compounds in low titre. The major of these 10 (6 mg L1) had a
molecular formula of C13H19NO4 (observed HRMS of 276.1219,
calculated 276.1206 for [M]Na+), one oxygen more than the
dephenylated 2-pyridone 9. 1H NMR indicated that none of the
C–H protons of 9 were missing, and signicant chemical shi
perturbations of H-5 and H-6 showed that the oxidationmust be
on the pyridone nitrogen. This conclusion was conrmed by 2D
NMR. The second compound 11 (3 mg L1) had a similar 1H
NMR to 10 featuring an additional 3-proton singlet at 3.93 ppm.
HRMS indicated a molecular formula of C14H22NO4 consistent
with a methylation of 10 (observed HRMS of 290.1368, observed
290.1363 for [M]Na+). Further 1D and 2D NMR experiments
indicated that the new methyl was attached to the N-hydroxyl.
Finally another minor compound was puried (4 mg L1).
This proved to be the dehydrated compound 12 (observed
HRMS of 352.1528, calculated 352.1520 for [M]Na+). In order to
determine the geometry of the C-5/C-14 olen of 12 several3848 | Chem. Sci., 2013, 4, 3845–3856methods were attempted. Although crystals of 12 could be
prepared, they did not diﬀract X-rays suﬃciently well to be able
to determine the structure. NOESY and ROESY NMR experi-
ments were also performed. These suggested that the NH was
proximal to the phenyl protons but the exchangeability of the
NH meant that unambiguous evidence for the geometry could
not be gained this way. Finally, the 3JHC coupling constant
between H-14 and C-4 was measured using an EXSIDE experi-
ment.21 The observed value of 3.5 Hz is consistent with a cis
relationship of these atoms, and DFT calculations of the 3JHC
values for the two possible E/Z isomers of 12 reinforced this
conclusion with calculated values of 4.5 Hz and 7.5 Hz for the cis
and trans geometries respectively.
The apdD gene encodes an FAD-dependent monooxygenase
and Hertweck and coworkers speculated that this might be
involved in hydroxylation of aspyridone A 1 to form aspyridone
B 2. We thus expressed apdA, apdC and apdE along with apdD.
Once again this experiment resulted in no new compounds, and
the overall titre was again lowered, this time to ca 70 mg L1.
The role of apdG was investigated in a ve-way experiment
featuring expression of apdA, apdC and apdE (which make
aspyridone A 1) along with apdB and apdG. This experiment was
achieved by expressing apdABCE as previously described, and
introducing a second vector carrying apdG driven by PgpdA. This
vector carries a selection marker consisting of the bleomycin
resistance gene ble downstream of PtrpC. However, thisThis journal is ª The Royal Society of Chemistry 2013
Fig. 4 Comparison of the productivity of A. nidulans SB4.1 (trace A) and A.
oryzae apdACEB (trace B).
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View Article Onlineexperiment did not result in the production of any new
compounds, giving approximately the same distribution of
compounds as expression of apdABCE alone.
Finally we compared the productivity of the A. nidulans SB4.1
strain with that of the A. oryzae apdACEB strain. A. nidulans
SB4.1 was grown in fermentation broth and extracted with
EtOAc (aﬀording 1069 mg L1 of crude extract). LCMS analysis
was performed and the results compared to the A. oryzae
extracts. Comparison of the LCMS traces showed that in ourScheme 1 Biosynthetic pathways of aspyridone A 1 and tenellin 3.
This journal is ª The Royal Society of Chemistry 2013hands the A. nidulans SB4.1 strain produced a similar range
of compounds to the A. oryzae apdACEB strain. The major
components were the two preaspyridone A diastereomers 5 and
6, with lesser amounts of the 14-hydroxy compound 8 and the
anhydro compound 12. Hertweck and coworkers reported
aspyridone A 1 as the major component, but in our hands the A.
nidulans SB4.1 strain produced this compound in low titre, and
did not appear to produce aspyridone B 2 at all. The depheny-
lated compounds were also not observed by us or the previous
investigators in the SB4.1 strain (Fig. 4).Discussion
Combinations of the putative aspyridone biosynthetic genes
and a heterologous combination of aspyridone genes with tenA
from the tenellin biosynthetic cluster were easily constructed in
our expression vector. Transcription of each gene was
conrmed by qRT-PCR,† conrming our previous observation
that all promoters are active in this system.13 Expression of apdA
and apdC alone led to the formation of preaspyridone A dia-
stereomers 5 and 6 in agreement with the in vitro results of Tang
and coworkers.17 Similar biosynthetic chemistry has been
shown to operate during the biosynthesis of pretenellin A 13
and many other related compounds including the cytochala-
sans.22,23 In brief, the hrPKS-NRPS builds a polyketide, in this
case a dimethyltetraketide which is linked to L-tyrosine by the
NRPS, which then catalyses a Dieckmann cyclisation to form the
acyl tetramic acid ring and release it from the synthetase.20,24 InChem. Sci., 2013, 4, 3845–3856 | 3849
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View Article Onlinethe case of the aspyridone synthetase Tang and coworkers have
shown in in vitro experiments that the NRPS module displays
extended substrate selectivity, utilising L-phenylalanine, L-p-
uorophenylalanine and L-tryptophan in addition to L-tyro-
sine.17 Our results tend to conrm this observation, insofar as
the formation of 7 is most easily explained as the result of uti-
lisation of phenylalnine in vivo. The incorporation of D-tyrosine
most simply explains the formation of 6.
Preaspyridone A 5 is the substrate for oxidative modication
catalysed by the cytochrome P450 monooxygenase ApdE. Again,
similar enzymes are known – for example TenA converts the
tetramic acid pretenellin A 13 to the 2-pyridone pretenellin B 14
(Scheme 1). In the case of apdE, however, the chemistry is more
diverse with three products being formed. The expected 2-pyr-
idone 1 is observed, but so are the 14-hydroxylated compound 8
and the 5-dephenylated pyridone 9. The formation of both
compounds can be explained by oxidative mechanisms. In the
case of TenA it is thought that hydrogen atom abstraction from
the benzylic carbon leads to a benzylic radical 16 which can
rearrange and eliminate to form the observed 2-pyridone
nucleus (Scheme 2).4 Benzylic alcohols such as 8 are not thought
to be intermediates in the ring expansion in the case of TenA.4
In the case of ApdE it appears that a benzylic radical could also
be formed. One reaction pathway would lead to the observedScheme 2 Oxidative mechanisms leading to 2-pyridones and b-hydroxy tetramic
3850 | Chem. Sci., 2013, 4, 3845–38562-pyridone by the same rearrangement that occurs for tenellin,
but the benzylic radical could also be hydroxylated directly
(rebound mechanism) to form the observed alcohol 8. It
appears unlikely that this oxidation could be catalysed by an
adventitious enzyme in A. oryzae as the 14-hydroxylated
compound 8 is not formed when apdA and apdC are expressed
alone. Furthermore, the equivalent compound in the tenellin
series, prototenellin-D 15 is not observed when tenS, tenC and
the P450-encoding tenA genes are expressed in A. oryzae, but is
only observed in extracts of the native host Beauveria bassiana,
again suggesting that B. bassiana contains a similar adventi-
tious enzyme not present in A. oryzae.
It also appears that the enzyme ApdE is responsible for the
oxidative dephenylation of preaspyridone A 5. Hydroxylation at
the phenyl-bridgehead carbon, leads to a putative hydroxy-
quinone 17 (Scheme 2) which could undergo a coupled ring-
expansion and dephenylation. Such hydroxyquinones are known
in natural products such as jacaglabroside B 18.25 Similar
compounds have also been synthesised from para-hydroxyar-
omatic species bymildoxidants includingbisacetoxyiodobenzene
and oxone.26 The product of the dephenylation was shown to be
derived from tyrosine, like its precursor preaspyridone A 5,
because of a high incorporation of label from [1-13C]-tyrosine.
Thus, unlike TenA which is a highly selective ring-expandase,acids.
This journal is ª The Royal Society of Chemistry 2013
Fig. 5 Structural relationship between 9 and the atpenins.
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View Article OnlineApdE appears to bemuch less selective in its oxidation chemistry.
The experiments also showed that TenA appears to be highly
selective for its substrate as it couldnot act on thepreaspyridoneA
diastereomers 5/6 which are very similar to pretenellin A 13.
The production of 9 and its derivatives also sheds light on
the biosynthesis of a class of fungal metabolites known as the
atpenins 19–22 which are potent and specic inhibitors of
mitochondrial succinate-ubiquinone oxidoreductase (Fig. 5)
and important tools for studying respiration.27 Although clearly
related to other fungal 2-pyridones, the biosynthesis of the
atpenins has not been reported. Our results suggest that they
are likely to be the products of PKS-NRPS systems very similar or
identical to the apd cluster, but containing additional genes for
oxidation, methylation and chlorination of intermediate 9.
The polyketide moieties of 1, 6, 9 and all the atpenins 19–22
have been determined to feature pendant methyl groups which
are arranged anti. Pendant methyl groups are derived from S-
adenosyl methionine (SAM) during polyketide biosynthesis in
fungi, catalysed by a C-methyltransferase (CMeT) domain of the
PKS. However, the stereochemistry of the carbon bearing the
methyl is set by the enoyl reductase (ER, Scheme 3). In the case
of ApdA the ER of the PKS is known to be inactive, but ER
activity is provided in trans by ApdC. Fungal PKS are iterative,
that is a single set of catalytic domains acts again and again to
produce the polyketide chain. In the case of aspyridone 1 the
acetate starter unit is extended three times to produce the
observed tetraketide. Methylation and enoyl reduction must
occur during both the rst and second cycle of extension and
modication (Scheme 3). Remarkably it appears that the trans-
acting ER catalyses the reduction with opposite stereoselectivity
in each case to produce the observed anti dimethylation pattern.
This mirrors the recently reported activity of the hypothemycin
KR of the hrPKS Hpm8 from the fungus Hypomyces subiculosus
which also appears to be able to catalyse reactions in diﬀerent
PKS cycles with opposite stereoselectivities.28Scheme 3 Proposed biosynthesis of the aspyridone polyketide.
This journal is ª The Royal Society of Chemistry 2013The role of apdB was also demonstrated. This gene encodes
another cytochrome P450 monooxygenase. Initial experiments
showed that ApdB appears not to act on the tetramic acids 5 or
6. However, it does appear to N-hydroxylate the dephenylated
2-pyridone 9, forming 10 and 11. These compounds were only
observed in experiments where apdB was expressed and so this
is very unlikely to be a native reaction of the A. oryzae host.
Interestingly, although northern blotting experiments sug-
gested that apdB was expressed during the biosynthesis of
aspyridones in the native host A. nidulans, N-oxygenated
compounds were not observed and our experiments also appear
to rule out a role for apdB during aromatic ring hydroxylation to
form aspyridone B 2. Furthermore, the formation of the N–O-
methyl compound 11 must be catalysed by an endogenous A.
oryzae O-methyl transferase as none of the expressed genes was
predicted to encode proteins with methyltransferase activity.
We were then le with the possibility of either ApdD or ApdG
being involved in ring-hydroxylation of 1 to form aspyridone B
2. However expression of apdD or apdG with combinations of
the other genes which produce 1 did not lead to the formation
of 2 or related compounds. It thus appears possible that
aspyridone B 2 is formed in A. nidulans by an enzyme encoded
outwith the predicted apd gene cluster.
Precise titres of all puried compounds were measured by
making standard solutions of the puried metabolites and
using these to calibrate a standard HPLC method (Table 1).
Individual fungal expression clones were grown in triplicate and
the average titres of each metabolite determined by HPLC of
exhaustive organic extracts of each fermentation. Consideration
of the overall productivity of each clone (Table 1) shows that as
well as the chemical make-up of the extract varying by expres-
sion clone, the total amount of produced material also varies.
Previous work in Bristol, as well as by Vederas and coworkers
has already shown that hrPKS enzymes are more productive
when expressed together with their cognate trans-acting ER,
suggesting a direct protein–protein interaction between the
hrPKS and the ER.19,20 The results of the experiments reported
here show that the presence of a downstream cytochrome P450
can also boost the productivity of the system, from 60 mg L1 to
nearly 400 mg L1, again suggesting a higher-order protein–
protein organisation. Interestingly this phenomenon also
appears to occur when proteins are present which are not acting
as chemical catalysts. For example, the probable presence of
ApdB appears to increase the productivity of ApdA + ApdC
approximately 2-fold, despite the fact that ApdB has no
substrate to act on. Conversely, the probable presence of ApdBChem. Sci., 2013, 4, 3845–3856 | 3851
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View Article Onlineappears to lower the inuence of ApdE, perhaps indicating an
eﬀect of competition. However such arguments must remain
inconclusive in the absence of information about actual protein
concentrations in vivo.Conclusion
Heterologous expression of biosynthetic genes from the aspyr-
idone pathway has allowed the individual catalytic activities of
each encoded enzyme to be investigated and the intermediates
to aspyridone A 1 to be determined. It has also allowed the
unprecedented oxidative chemistry catalysed by ApdE to be
observed. ApdE shares 48% amino acid identity and 64%
similarity to TenA, but nevertheless these enzymes show
diﬀerent substrate selectivities and diﬀerent delities. The
activity of ApdE gives clues about the biosynthesis of the atpe-
nins and based on our results it should now be possible to
rapidly discover a putative atpenin biosynthetic gene cluster in
Penicillium sp. FO125, the producing organism.
Our results also raise questions about the identity and de-
nition of fungal biosynthetic gene clusters, their control and
their chemical products. Fungal biosynthetic gene clusters can
be dened by a number of means – including cotemporal
transcription, as demonstrated by Hertweck and coworkers in
the case of the apd genes,8 and by many bioinformatic means
(some even claiming accuracy29). It is clear that in the case of the
apd genes, apdA to apdG are cotemporally transcribed, seem-
ingly in response to the expression of apdR. However, not all of
these genes encode proteins which are catalytically active – only
apdA, apdC, and apdE are required for the synthesis of aspyr-
idone A 1. There appear to be insuﬃcient genes in the cluster to
encode the synthesis of aspyridone B 2, and transcription and
bioinformatic analyses are inadequate for determining the role
of apdB, or for predicting the new chemistry enacted by ApdE.
However, all these features were revealed by our heterologous
expression experiments.
Furthermore, our experiments show that heterologous
expression of genes using strong constitutive promoters can
signicantly enhance titres of the produced compounds – for
example expression of apdA and apdC alone aﬀords one major
compound at 61 mg L1, but coexpression with apdE increases
this signicantly to 390 mg L1 (but for three compounds). The
origin of this eﬀect is not directly discernible from our experi-
ments, but suggests that the productivity of the aspyridone
biosynthetic enzymes are enhanced when they work together.
The ability of genes from the apd cluster to encode the synthesis
of diverse compounds is exemplied by our coexpression of
apdABCE which produced at least seven diﬀerent compounds
attributable to the apd genes.
This result emphasises our previous observation that
diﬀerential gene expression levels during tenellin biosynthesis
in the native host Beauveria bassiana can aﬀect both titre and
biosynthetic programming,30 in turn indicating that ne control
over gene expression can aﬀect the chemical structures of the
compounds produced from a single biosynthetic gene cluster.
This can occur in eukaryotes where each structural gene is
controlled by its own promoter and where complex networks of3852 | Chem. Sci., 2013, 4, 3845–3856control elements are involved in the activation of genes within
each pathway. In our experiments where this ne control has
been bypassed we assume that the relative ratios of the
produced proteins is diﬀerent from that produced under native
conditions. It has long been known that the production of
individual secondary metabolites by lamentous fungi is very
sensitive to growth and media conditions, but our results also
suggest that changes in gene expression could also change the
compounds produced from a single gene cluster.
Clear lessons emerge from this analysis: rst, that the de-
nition of fungal biosynthetic gene clusters, however achieved, is
at best speculative; second, that heterologous expression can
reveal a signicant number of the details of secondary meta-
bolic pathways in fungi; third, that the ability of fungal path-
ways to produce (many) more than one compound is inherent –
and that a single compound should not be regarded as the sole
product of a fungal biosynthetic gene cluster; fourth, that
genomemining in fungi will remain problematic while so many
gene expression pathways, enzymatic activities and protein–
protein interactions remain highly unpredictable; and nally
that heterologous expression oﬀers a systematic and broadly
applicable method for investigating the chemistry of silent
and orphan fungal biosynthetic gene clusters, in addition to
providing access to new natural products.Experimental
1 Cloning procedures
All primer sequences are given in the ESI.†
1.1 Construction of pTAYAargAC (apdA, apdC). PgpdA, apdC
and Peno were amplied from pTAYAargASP (ABCE) as a single
fragment using primers newgpdA-F, eno/asc/Page-R, while Padh
was amplied using primers adh/asc-F and adh/asc-R. These
fragments were reassembled by homologous recombination in
S. cerevisiae with Asc1-cut pTAYAGSargPage and shuttled back
into E. coli to create pTAYAGSargapdC. apdAeGFP was then
transferred into pTAYAGSargapdC by Gateway LR recombina-
tion to create pTAYAargAC. Transformation of A. oryzae with
this plasmid yielded 42 transformants and metabolites were
extracted from 9.
1.2 Construction of pTAYAargACE (apdA, apdC, apdE). The
apdB gene was removed from pTAYAargASP by homologous
recombination in yeast. pTAYAargASP was linearized withMlu1
which cuts at a unique site within apdB. Amplication of Peno
with primers eno/asc/page-F and eno/asc/page-R produced a
‘patch’ fragment that could recombine both up- and down-
stream of the apdB coding region. This created pTAYAargACE,
which carries only apdA, apdC and apdE. Analytical digestion
with HindIII yielded 3 fragments of 23 699, 1071, 3955 bp con-
rming the removal of apdB, which contains an additional
HindIII site. This plasmid was used to transform A. oryzaeM-2-3.
Metabolites were extracted from 11 of the 12 transformants
recovered.
1.3 Construction of pTAYAargABC (apdA, apdB, apdC).
Three fragments, PgpdA + apdC (3631 bp), apdB (2264 bp) and
Padh (500 bp) were amplied from pTAYAargASP using the
primers: PgpdA plus apdC, newgpdA-F and gpdA-apdC-R; apdC,This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineenoapdB-F and enoapdB-R; apdE, adh/asc-F and adh/asc-R.
These fragments were reassembled in yeast with Asc1-cut
pTAYAGSargPage to create pTAYAGSargBC. Finally, apdAeGFP
(see Construction of pTAYAargASP) was inserted to create
pTAYAargABC, which was used to transform A. oryzae. Thirty
three transformants were recovered, metabolites were extracted
from 8 of these, with 7 of them showing high titres of
preaspyridone.
1.4 Construction of pTAYAargACtenA (apdA, apdC, tenA).
PgpdA, apdC and Peno were amplied from pTAYAargASP as a
single fragment using primers newgpdA-F and eno/asc/Page-R,
while tenA was amplied together with Padh from pTAYAG-
SargPageTenellin13 using primers adh/asc-F and trporf1-R.
These fragments were reassembled in AscI-cut pTAYAGSargPage
by homologous recombination in S. cerevisiae, creating
pTAYAGSargCtenA. Plasmids were recovered in E. coli and the
correct clone was used as a vector for insertion of apdAeGFP via
LR recombination to create pTAYAargACtenA. This plasmid was
used to transform A. oryzae. Forty two transformants were
recovered and metabolites were extracted from 14. Of these, 11
produced new compounds.
1.5 Construction of pTAYAargASP (apdA, apdB, apdC,
apdE). The genes for the three tailoring enzymes of aspyridone
biosynthesis were amplied using the following primers: apdE,
adh-apdE-F and adh-apdE-R; apdC, gpdA-apdC-F and gpdA-
apdC-R; apdB, eno-apdB-F, eno-apdB-R. The primers produced
overlaps with the promoters and anking vector sequences and
the coding regions were each amplied together with 300 bp of
30-UTR from genomic DNA of A. nidulans; the product sizes were
1980 bp, 1461 bp and 2264 bp. Recombination in yeast was used
to combine the fragments and the resultant plasmids were
shuttled to E. coli. Following analytical PCR, plasmids from two
colonies were extracted and restriction analysis indicated that
all 3 genes were present in both.
The apdA gene was amplied from A. nidulans genomic DNA
as three overlapping fragments of 4 kb each using primer
pairs: apdA1-F and apdA1-R; apdA2-F and apdA2-R; apdA3-F
and apdA3-R. The forward primer for fragment 1 and reverse
primer for fragment 3 contained 30 bases homologous to the
vector region for recombination. Homologous recombination in
S. cerevisiae was used to reassemble apdA between GATEWAY
attL sites to allow easy transfer into any expression vector that
contains a GATEWAY destination cassette. pEYAtenSeGFP13 was
digested with Not1 and Xho1 and used as the vector. The tenS
gene was replaced by apdA, while the eGFP remained to facili-
tate identication of A. oryzae transformants that successfully
expressed the new hybrid gene. Plasmids extracted from
S. cerevisiae colonies were shuttled into E. coli TOP10 cells. Four
colonies were extracted and the plasmids digested with Not1
plus Kpn1 to prove that apdA had been correctly assembled to
create pEYAapdAeGFP. GATEWAY LR recombination between
pEYAapdAeGFP and pTAYAGSargPageASP resulted in produc-
tion of pTAYAargASP ready to transform A. oryzae.
Fiy nine colonies were recovered following transformation
of A. oryzae with pTAYAargASP. All transformants were sub-
cultured onto selective medium. In order to conrm all the
genes in the pTAYAargASP were expressed, qRT-PCR wasThis journal is ª The Royal Society of Chemistry 2013performed (see ESI†). Fourteen transformants were cultured
for metabolite extraction. All 14 had a yellow pigmented
morphology, but one was discarded due to contamination. In all
13 extracts analysed, new compounds were detected.
1.6 Construction of pTAYAargACED (apdA, apdC, apdE,
apdD). Plasmid pTAYAargACED was constructed from
pTAYAargASP using the same strategy as that used to create
pTAYAargACE. apdD was amplied using primers apdD-F and
apdD-R which anked the PCR product with sequences over-
lapping the enolase promoter and vector sequences respectively.
Following recombination in S. cerevisiae and plasmid recovery in
E. coli, three colonies were miniprepped and the plasmids were
conrmed by restriction digestion. This plasmid was used to
transform A. oryzae, and metabolites were extracted from 5
transformants. Of these, 4 produced new compounds. The
presence of apdD in the transformant was conrmed by PCR.
1.7 Co-transformation of A. oryzae with pTAYAargASP
(carrying apdABCE) and pTAYAGSbleG (carrying apdG).
pTAYAGSbarPage was created by homologous recombination in
S. cerevisiae. Age1-cut pTAYAGSargPage was recombined with
PCR fragments of PtrpC + bar (YA-TrpC-F and Bar-YA-R) and PgpdA
(newgpdA-F and newgpdA-R) and plasmids were shuttled back
into E. coli. Age1 cuts twice in both the arg gene and PgpdA. Thus,
while the PtrpC + bar fragment replaced the arg gene, the PgpdA
fragment provided a ‘patch’ to allow the plasmid to recircular-
ize. Clones containing the desired plasmid pTAYAGSbarPage
were identied by PCR. This plasmid was further modied by
replacing the bar gene with ble.
The ble gene was amplied and inserted into NgoMIV-cut
pTAYAGSbarPage by homologous recombination in yeast to
create pTAYAGSblePage. The plasmid was conrmed to
carry the ble-resistance gene by restriction analysis with Ngo-
MIV + Asc1.
pTAYAGSblePage was then used as a vector to co-express
apdG together with pTAYAargASP in A. oryzae. The apdG gene
was amplied using the primers apdG-F and apdG-R and placed
under control of PgpdA in Asc1-cut pTAYAGSblePage. Two
promoter fragments (PgpdA + Padh and Peno) were also amplied
(PgpdA + Padh, adh/asc-F and newgpdA-R; Peno, eno/asc/page-F
and eno/asc/page-R) and inserted to ‘patch’ the Asc1 sites
downstream of Padh and Peno in Asc1-cut pTAYAGSblePage. The
resulting plasmid, pTAYAGSbleG was recovered in E. coli and
conrmed by restriction digestion with NgoMIV.
Twelve transformants were obtained by co-transformation of
A. oryzae with pTAYAargASP (carrying apdABCE) and
pTAYAGSbleG (carrying apdG). Transformants were selected on
a minimal medium containing 100 mg mL1 zeocin (a cheaper
alternative to bleomycin or phleomycin). Metabolites were
extracted from all 12 transformants, but novel peaks were
detected in only 5.
1.8 Construction of vector pTAYAGSargPage. The Padh,
PgpdA and Peno promoters were amplied by PCR using sets of
primers (adh/asc-F, adh/asc-R, newgpdA-F, newgpdA-R, eno/
asc-Page-F and eno/asc-Page-R respectively) with 50 extensions
that provided overlap between adjacent promoters and the
vector insertion site, as well as providing Asc1 sites downstream
of each promoter. They were inserted into NgoMIV-cutChem. Sci., 2013, 4, 3845–3856 | 3853
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View Article OnlinepTAYAGSarg13 via homologous recombination in yeast, and
resultant plasmids were shuttled into E. coli. Four E. coli colo-
nies were screened by restriction digestion with Asc1. Of these,
three showed the expected restriction pattern for pTAYAG-
SargPage, while the fourth lacked the Peno fragment. Analytical
PCR was further done on the clones to verify successful inser-
tion of the promoters in the correct orientation using combi-
nations of primers: adh/asc-F and gpdA-R (for Padh and PgpdA),
gpdA-F and eno/asc-R (PgpdA and Peno).
2 Fermentation conditions
The Aspergillus oryzae transformants were rst grown on Czapek
Dox Agar (minimal media, see ESI†) and for further production
of spores, they were inoculated and grown on DPY solid media
for 7–10 days at 25 C.
2.1 Culturing and inoculation of spores of A. oryzae
transformants in liquid media. 10 mL of deionized water was
added on DPY plates having 10 days old growing spores of the
transformants. The spores were made to pass into the deionized
water by careful scratching the surface with sterilized loop.
The spore suspension (1 mL) from the plate was added in each
100 mL liquid medium contained in 250 mL Erlenmeyer ask.
The spores were allowed to grow in the liquid culture for 7 days
on shakers at 200 rpm at 28 C.
2.2 Extraction. Cells and media (1 L) were homogenized
using a hand-held electric blender and then acidied to pH 4.0
using 37%HCl. An equal volume of ethyl acetate was added and
stirred for 10 min. The resulting mixture was vacuum ltered
throughWhatman no. 1 lter paper. The ltrate was transferred
into a separating funnel and shaken vigorously. The mixture
was allowed to stand to separate the layers. The organic layer
was washed once with concentrated brine solution and then
with deionized water. The organic phase was dried (MgSO4),
ltered and evaporated to dryness. The crude extract was dis-
solved in 10% aqueous methanol and defatted by extraction
with hexane. The methanolic layer was evaporated to dryness
and then made into a solution of 10 mg mL1 in HPLC grade
methanol and analysed by LCMS.
For purication of compounds the crude extract was made
into a solution of 50 mg mL1 in HPLC grade methanol and
200 mL aliquots were injected in each run of mass-directed
HPLC preparative purication.
3 Analytical LCMS
Samples as prepared above (20 mL) were analysed using aWaters
2795HT HPLC system. Detection was achieved by uv between
200 and 400 nm using a Waters 998 diode array detector, and by
simultaneous electrospray (ES) mass spectrometry using a
Waters ZQ spectrometer detecting between 150 and 600 m/z
units. Chromatography (ow rate 1 mL min1) was achieved
using a Phenomenex Kinetex column (2.6 m, C18, 100 A˚, 4.6 
100 mm) equipped with a Phenomenex Security Guard pre-
column (Luna C5 300 A˚). Solvents were: A, HPLC grade H2O
containing 0.05% formic acid; B, HPLC grade MeOH containing
0.045% formic acid; and C, HPLC grade CH3CN containing
0.045% formic acid. Gradients were as follows.3854 | Chem. Sci., 2013, 4, 3845–3856Method 1. MeOH: 0min, 10% B; 10 min, 90% B; 12 min, 90%
B; 13 min, 10% B; 15 min, 10% B.
Method 2. CH3CN: 0 min, 10% C; 10 min, 90% C; 12 min,
90% C; 13 min, 10% C; 15 min, 10% C.4 Purication and characterization of compounds
Purication of compounds was generally achieved using a
Waters mass-directed autopurication system comprising of a
Waters 2767 autosampler, Waters 2545 pump system, a Phe-
nomenex LUNA column (5m, C18, 100 A˚, 10 250 mm) equipped
with a Phenomenex Security Guard precolumn (Luna C5 300 A˚)
eluted at 4 mL min1. Solvent A, HPLC grade H2O + 0.05%
formic acid; Solvent B, HPLC grade MeOH + 0.045% formic
acid; solvent C, HPLC grade CH3CN + 0.045% formic acid. The
post-column ow was split (100 : 1) and the minority ow was
made up with solvent A to 1 mL min1 for simultaneous anal-
ysis by diode array detector (Waters 2998), evaporative light
scattering (Waters 2424) and ESI mass spectrometry in positive
and negative modes (Waters Quatro Micro).
Solvent used were: A, HPLC grade water containing 0.05%
formic acid; and Solvent B, HPLC grade CH3CN containing
0.045% formic acid. Extracts from (apdACEB) were puried with
Method 1, (apdACED) with Method 2, (apdACE) with Method 3
and (apdACEBG) with Method 4.
Method 1: 0 min, 50% B; 22 min, 75% B; 24 min, 95% B;
26 min, 95% B; 27 min, 50% B; 30 min, 50% B.
Method 2: 0 min, 55% B; 22 min, 60% B; 24 min, 95% B;
26 min, 95% B; 27 min, 55% B; 30 min, 55% B.
Method 3: 0 min, 55% B; 22 min, 75% B; 24 min, 95% B;
26 min, 95% B; 27 min, 55% B; 30 min, 55% B.
Method 4: 0 min, 50% B; 22 min, 65% B; 24 min, 95% B;
26 min, 95% B; 27 min, 50% B; 30 min, 50% B.
Detected peaks were collected into glass test tubes.
Combined fractions were evaporated under a ow of dry N2 gas
and residues weighed and dissolved directly in NMR solvent for
NMR analysis.
4.1 Aspyridone A 1 (ref. 8) Light brown solid, IR (neat): nmax
2961, 2928, 1648, 1610, 1516, 1458, 1378, 1217, 1175, 992, 835,
588 cm1. 1H NMR (CD3OD, 500 MHz) d ¼ 0.89 (t, J ¼ 7.5 Hz,
3H, H-12), 0.92 (d, J ¼ 6.5 Hz, 3H, H-13), 1.15 (d, J ¼ 6.5 Hz, 3H,
H-14), 1.18 (m, 1H, H-11a), 1.35 (m, 1H, H-9a), 1.37 (m, 1H, H-
11b), 1.43 (m, 1H, H-10), 1.65 (m, 1H, H-9b), 4.40 (q, J ¼ 6.8 Hz,
1H, H-8), 6.83 (d, J¼ 8.5 Hz, 1H, H-17, H-19), 7.29 (d, J ¼ 8.5 Hz,
1H, H-16, H-20) 7.49 (s, 1H, H-6); 13C NMR (CD3OD, 125 MHz): d
11.7 (C-12), 17.6 (C-14), 19.4 (C-13), 30.9 (C-11), 33.6 (C-10), 41.2
(C-9), 41.8 (C-8), 107.0 (C-3), 116.0 (C-5), 116.15 (C-17, C-19),
125.1 (C-15), 131.5 (C-16, C-20) 140.6 (C-6), 158.3 (C-18), 163.9
(C-4), 177.6 (C-2), 214.3 (C-7).
4.2 Preaspyridone A (major diastereomer) 5 (ref. 17) Pale
brown solid, IR (neat): nmax 3020, 2964, 1653, 1602, 1214 cm
1
1H NMR (500 MHz, DMSO d6) d ¼ 0.80 (m, 3H, H-12), 0.79 (m,
3H, H-11), 0.95 (d, J ¼ 7 Hz, 3H, H-13), 1.07 (m, 1H, H-10a), 1.28
(m, 1H, H-9), 1.29 (m, 1H, H-10b), 1.29 (m, 1H, H-8a), 1.37 (m,
1H, H-8b), 2.82 (d, J ¼ 4.5 Hz, 2H, H-14), 3.51 (q, J ¼ 6.6 Hz, 1H,
H-7), 4.08 (brs, 1H, H-5), 6.59 (d, J ¼ 8.5 Hz, 2H, H-17, H-19),
6.89 (d, J¼ 8 Hz, 2H, H-16, H-20), 8.92 (s, 1H, H-1), 9.16 (brs, 1H,This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineH-18); 13C NMR (125 MHz, DMSO d6), 10.9 (C-11), 17.1 (C-13),
18.9 (C-12), 28.6 (C-10), 31.7 (C-9), 33.5 (C-7), 35.7 (C-14), 39.1 (C-
8), 62.4 (C-5), 99.8 (C-3), 114.7 (C-17, C-19), 125.3 (C-15), 130.6
(C-16, C-20), 155.7 (C-18), 175.6 (C-2), 194.3 (C-4), 191.9 (C-6).
4.3 Preaspyridone A (minor diastereomer) 6. Crystalline
solid, IR (neat): nmax 3262, 2962, 1693, 1650, 1589 cm
1; 1H NMR
(500 MHz, DMSO d6) d ¼ 0.79 (m, 3H, H-12), 0.82 (m, 3H, H-11),
1.02 (d, J¼ 6 Hz, 3H, H-13), 1.09 (m, 1H, H-10a), 1.21 (m, 1H, H-
9), 1.26 (m, 1H, H-10b), 1.27 (m, 2H, H-8), 2.81 (dd, 1H, J¼ 5 Hz,
J ¼ 15 Hz, H-14a), 2.87 (dd, 1H, J ¼ 5 Hz, J ¼ 15 Hz, H-14b), 3.51
(q, J¼ 6.8 Hz, 1H, H-7), 4.07 (brs, 1H, H-5), 6.57 (d, J¼ 8 Hz, 2H,
H-17, H-19), 6.88 (d, J ¼ 8.5 Hz, 2H, H-16, H-20), 8.93 (s, 1H, H-
1), 9.14 (brs, 1H, H-18); 13C NMR (125 MHz, DMSO d6), 10.8 (C-
11), 16.7 (C-13), 18.9 (C-12), 28.7 (C-10), 31.5 (C-9), 33.4 (C-7),
35.4 (C-14), 39.6 (C-8), 62.3 (C-5), 99.9 (C-3), 114.7 (C-17, C-19),
125.3 (C-15), 130.6 (C-16, C-20), 155.7 (C-18), 175.4 (C-2), 194.4
(C-4), 191.9 (C-6).
4.4 18-Deshydroxypreaspyridone A 7. Light brown solid, IR
(neat): nmax 3019, 2962, 2875, 1709, 1656, 1600, 1214 cm
1. 1H
NMR (500 MHz, CD3OD) d¼ 0.83 (m, 3H, H-11), 0.84 (m, 3H, H-
12), 1.02 (d, J ¼ 7 Hz, 3H, H-13), 1.09 (m, 1H, H-10a), 1.27 (m,
1H, H-9), 1.34 (m, 1H, H-10b), 1.31 (m, 1H, H-8a), 1.45 (m, 1H,
H-8b), 2.98 (dd, J¼ 5.5, 14 Hz, 1H, H-14a), 3.07 (dd, J¼ 4, 14 Hz,
1H, H-14b), 3.66 (q, J ¼ 6.7 Hz, 1H, H-7), 4.11 (t, J ¼ 4.5 Hz, 1H,
H-5), 7.16 (m, 2H, H-17, H-19), 7.17 (m, 1H, H-18), 7.22 (m, 2H,
H-16, H-20); 13C NMR (125 MHz, CD3OD): d ¼ 11.8 (C-11), 17.9
(C-13), 19.8 (C-12), 30.6 (C-10), 33.8 (C-9), 36.0 (C-7), 38.6 (C-14),
41.6 (C-8), 63.5 (C-5), 128.1 (C-18), 129.5 (C-16, C-20), 131.2 (C-
17, C-19), 137.2 (C-15), 196.0 (C-6), 197.7 (C-4), 214.3 (C-2).
4.5 14-Hydroxypreaspyridone A 8. Pale brown solid, IR
(neat): nmax 3317, 3020, 2964, 1651, 1214 cm
1. 1H NMR (500
MHz, CD3OD) d ¼ 0.78 (m, 3H, H-11), 0.79 (m, 3H, H-12), 0.92
(d, J ¼ 6.5 Hz, 3H, H-13), 1.06 (m, 1H, H-10a), 1.19 (m, 1H, H-9),
1.25 (m, 1H, H-8a), 1.36 (m, 1H, H-10b), 1.38 (m, 1H, H-8b), 3.54
(q, J ¼ 7 Hz, 1H, H-7), 4.18 (d, J ¼ 3.5 Hz, 1H, H-5), 4.94 (d, J ¼ 4
Hz, 1H, H-14), 7.12 (d, J ¼ 8.5 Hz, 2H, H-16, H-20), 6.65 (d, J ¼
8.5 Hz, 2H, H-17, H-19); 13C NMR (125 MHz, CD3OD): d ¼ 11.6
(C-11), 17.9 (C-13), 19.8 (C-12), 30.4 (C-10), 33.8 (C-9), 35.8 (C-7),
41.7 (C-8), 68.5 (C-5), 75.1 (C-14), 115.7 (C-17, C-19), 129.8 (C-16,
C-20), 130.5 (C-15), 158.4 (C-18).
4.6 4-Hydroxy-3-(2,4-dimethylhexanoyl) 2-pyridone 9. Pale
beige solid, IR (neat): nmax 3408, 3298, 2923, 2287, 1734, 1601,
1462, 1227 cm1. 1H NMR (500 MHz, DMSO d6) d¼ 0.79 (m, 3H,
H-12), 0.81 (m, 3H, H-13), 1.02 (d, J ¼ 7 Hz, 3H, H-14), 1.09 (m,
1H, H-11a), 1.21 (m, 1H, H-9a), 1.25 (m, 1H, H-11b), 1.33 (m, 1H,
H-10), 1.49 (m, 1H, H-9b), 4.22 (q, J¼ 7 Hz, 1H, H-8), 5.92 (d, J¼
7.5 Hz, 1H, H-5), 7.60 (t, J ¼ 6.5, 7 Hz, 1H, H-6), 11.47 (s, 1H, H-
1); 13C NMR (125 MHz, DMSO d6): d 10.9 (C-12), 16.7 (C-14),
211.6 (C-7), 18.4 (C-13), 29.4 (C-11), 31.6 (C-10), 39.9 (C-8), 40.0
(C-9), 98.9 (C-5), 105.6 (C-3), 142.6 (C-6), 161.8 (C-4), 177.4 (C-2).
4.7 1,4-Dihydroxy-3-(2,4-dimethylhexanoyl) 2-pyridone 10.
Light brown solid, IR (neat): nmax 3104, 2928, 1731, 1635, 1611,
1453, 1200, 751 cm1. 1H NMR (500 MHz, CD3OD) d ¼ 0.87 (t,
J¼ 7.2 Hz, 3H, H-12), 0.92 (d, J¼ 7 Hz, 3H, H-13), 1.13 (d, J¼ 6.5
Hz, 3H, H-14), 1.18 (m, 1H, H-11a), 1.31 (m, 1H, H-9a), 1.35 (m,
1H, H-11b), 1.41 (m, 1H, H-10), 1.61 (m, 1H, H-9b), 4.32 (q, J¼ 7
Hz, 1H, H-8), 5.99 (d, J ¼ 8 Hz, 1H, H-5), 7.96 (d, J ¼ 7.5 Hz, 1H,This journal is ª The Royal Society of Chemistry 2013H-6); 13C NMR (125 MHz, CD3OD): d 11.7 (C-12), 17.3 (C-14),
19.3 (C-13), 31.0 (C-11), 33.5 (C-10), 40.6 (C-9), 42.1 (C-8), 98.9
(C-5), 107.3 (C-3), 142.3 (C-6), 175.8 (C-2), 213.8 (C-7).
4.8 1-Methoxy, 4-hydroxy-3-(2,4-dimethylhexanoyl) 2-pyr-
idone 11. Light brown solid, IR (neat): nmax 2961, 2930, 1661,
1611, 1465, 1388, 975 cm1. 1H NMR (500 MHz, DMSO d6) d ¼
0.80 (t, J ¼ 7.2 Hz, 3H, H-12), 0.84 (d, J ¼ 6.5 Hz, 3H, H-13), 1.03
(d, J ¼ 7 Hz, 3H, H-14), 1.13 (m, 1H, H-11a), 1.25 (m, 1H, H-9a),
1.25 (m, 1H, H-11b), 1.37 (m, 1H, H-10), 1.49 (m, 1H, H-9b), 3.93
(s, 3H, H-15), 4.15 (q, J ¼ 7 Hz, 1H, H-8), 5.99 (d, J ¼ 7.5 Hz, 1H,
H-5), 8.24 (d, J ¼ 7.5 Hz, 1H, H-6); 13C NMR (125 MHz, DMSO
d6): d 11.1 (C-12), 16.5 (C-14), 18.6 (C-13), 29.4 (C-11), 31.8 (C-10),
39.6 (C-9), 39.9 (C-8), 64.4 (C-15), 98.4 (C-5), 146.2 (C-6), 109.9 (C-
3), 159.9 (C-2), 214.5 (C-7).
4.9 Z-5,14-Anhydropreaspyridone A 12. Bright yellow solid,
IR (neat): nmax 3667, 3190, 2961, 2876, 2366, 1691, 1584 cm
1. 1H
NMR (500MHz, DMSOd6) d¼ 0.79 (m, 3H,H-11), 0.82 (m, 3H,H-
12), 1.05 (d, J ¼ 6.5 Hz, 3H, H-13), 1.08 (m, 1H, H-10a), 1.32 (m,
1H, H-9), 1.32 (m, 1H, H-10b), 1.38 (m, 1H, H-8a), 1.47 (m, 1H, H-
8b), 3.75 (q, J¼ 6.6Hz, 1H,H-7), 6.37 (s, 1H,H-14), 6.78 (d, J¼ 8.5
Hz, 2H,H-17, H-19), 7.46 (d, J¼ 8.5Hz, 2H,H-16, H-20); 13CNMR
(125MHz,DMSOd6): d¼ 10.9 (C-11), 16.8 (C-13), 18.8 (C-12), 28.7
(C-10), 31.5 (C-9), 40.4 (C-8), 110.4 (C-14), 115.6 (C-17,C-19), 124.8
(C-15), 131.5 (C-16, C-20), 158.8 (C-18), 184.0 in CD3OD (C-4).
4.10 Crystal structure data. Crystal structure data has been
deposited with the CCDC under the following accession
numbers: 6, 941137; 1, 941138; 9, 941139.
5 3JCH coupling constant calculations
The values of 3JCH for the cis and trans isomers of 12 were
established by computation of a truncated analogue with the
polyketide sidechain removed (see ESI†). The geometries were
optimised with DFT/B3LYP functional using 631g basis set
before calculation of coupling constants using the Gauge Inde-
pendent Atomic Orbital (GIAO) approach with a 631g+(d,p) basis
set. All calculations were performed in Gaussian09.31 Geometry
optimisation and 3JCH calculations were repeated for the corre-
sponding enol forms and found to give coupling constant values
in agreement with the corresponding enone forms, so no further
account of enolisation was considered in this analysis.
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